Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DD2C5E
|
|||
| Drug Name |
IONIS-416858
|
|||
| Synonyms |
IONIS-FXI-LRx
Click to Show/Hide
|
|||
| Drug Type |
Antisense oligonucleotide
|
|||
| Indication | Thrombosis [ICD-11: DB61-GB90] | Phase 2 | [1] | |
| Company |
Ionis Pharmaceuticals
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Factor XI messenger RNA (F11 mRNA) | Target Info | Inhibitor | [1] |
| KEGG Pathway | Complement and coagulation cascades | |||
| Pathwhiz Pathway | Coagulation | |||
| Reactome | Intrinsic Pathway of Fibrin Clot Formation | |||
| WikiPathways | Human Complement System | |||
| Blood Clotting Cascade | ||||
| Formation of Fibrin Clot (Clotting Cascade) | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of Ionis Pharmaceuticals. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.